- 9-α-FLUORO-17-α-METHYL-17-HYDROXY-4-ANDROSTENE-3,11-DIONE
- 9-((2-Phosphonylmethoxy)ethyl)guanine
- 9-((3-((2-Chloroethyl)amino)propyl)amino)acridine dihydrochloride hydrate
- 9-((3-((2-Chloroethyl)ethylamino)propyl)amino)-4-methoxyacridine dihydrochloride hemihydrate
- 9-((3-((2-Chloroethyl)ethylamino)propyl)amino)acridine dihydrochloride
- 9-((3-(Bis(2-chloroethyl)amino)propyl)amino)acridine dihydrochloride
- 9-(1,1,2-Trimethylpropoxy)-9-borabicyclo[3.3.1]nonane
- 9(10)-Dehydronandrolone
- 9(10H)-Acridinone, 2-chloro-10-phenyl-
- 9(10H)-Acridinone,10-(phenylmethyl)-
- 37686-85-4trans-9,10-DIHYDROLISURIDE HYDROGEN MALEATE
- 37687-24-41H-Pyrazole-3,5-dicarboxylicacid, 3,5-diethyl ester
- 37688-96-3Tetradecane,1,14-dibromo-
- 37689-22-8Benzene,2-cyclopenten-1-yl-
- 376-90-91,5-Pentanediol,2,2,3,3,4,4-hexafluoro-
- 37691-11-5L-Valinamide,N2-[[(1-carboxy-2-phenylethyl)amino]carbonyl]-L-arginyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-
- 37693-01-9Phenol,2-[(2,4-dichlorophenyl)methyl]-4-(1,1,3,3-tetramethylbutyl)-
- 3769-41-3Phenol,3-(phenylmethoxy)-
- 3769-42-4Benzene,1,3-bis(phenylmethoxy)-
- 3769-57-1Ethanol,2,2'-[[4-[2-(2-chloro-4-nitrophenyl)diazenyl]-3-methylphenyl]imino]bis-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
9,10a-Dihydrolisuride |
EINECS | N/A |
| CAS No. | 37686-84-3 | Density | 1.21g/cm3 |
| PSA | 51.37000 | LogP | 3.26050 |
| Solubility | N/A | Melting Point |
203-204° (dec); mp 205-207° (dec) (Cerny) |
| Formula | C20H28 N4 O | Boiling Point | 588°C at 760 mmHg |
| Molecular Weight | 340.469 | Flash Point | 309.4°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion and intravenous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | 23/24/25 |
| Molecular Structure |
|
Hazard Symbols | T |
| Synonyms |
Ergoline,urea deriv.; Indolo[4,3-fg]quinoline, urea deriv.; (+)-(5R,8S,10R)-Terguride;(+)-Terguride; (5R,8S,10R)-Terguride; 6-Methyl-8a-(diethylcarbamoylamino)ergoline; 9,10a-Dihydrolisuride;N,N-Diethyl-N'-(D-6-methyl-10a-isoergolin-8-yl)urea; TDHL; Tergurid; Terguride; trans-Dihydrolisuride |
Article Data | 9 |
9,10a-Dihydrolisuride Chemical Properties
Molecular Formula: C20H28N4O
Molar mass: 340.46 g/mol
EINECS: 253-624-2
Density: 1.21 g/cm3
Flash Point: 309.4 °C
Index of Refraction: 1.639
Boiling Point: 588 °C at 760 mmHg
Vapour Pressure: 8.3E-14 mmHg at 25°C
Solubility: DMSO: soluble
Form: Solid
Color: White
Structure of 9,10a-Dihydrolisuride (37686-84-3):
XLogP3-AA: 2.5
H-Bond Donor: 2
H-Bond Acceptor: 2
SMILES: O=C(N(CC)CC)N[C@H]2C[C@@H]3c4cccc1c4c(cn1)C[C@H]3N(C2)C
InChI: InChI=1/C20H28N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,11,14,16,18,21H,4-5,9-10,12H2,1-3H3,(H,22,25)/t14-,16+,18+/m0/s1
InChIKey: JOAHPSVPXZTVEP-YXJHDRRABA
Std. InChI: InChI=1S/C20H28N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,11,14,16,18,21H,4-5,9-10,12H2,1-3H3,(H,22,25)/t14-,16+,18+/m0/s1
Std. InChIKey: JOAHPSVPXZTVEP-YXJHDRRASA-N
9,10a-Dihydrolisuride Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| monkey | LD50 | oral | > 500mg/kg (500mg/kg) | Drugs in Japan Vol. -, Pg. 832, 1995. | |
| mouse | LD50 | intraperitoneal | 272mg/kg (272mg/kg) | GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS KIDNEY, URETER, AND BLADDER: HEMATURIA KIDNEY, URETER, AND BLADDER: INCONTINENCE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 329, 1993. |
| mouse | LD50 | intravenous | 75mg/kg (75mg/kg) | Collection of Czechoslovak Chemical Communications. Vol. 52, Pg. 2983, 1987. | |
| mouse | LD50 | oral | 160mg/kg (160mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS KIDNEY, URETER, AND BLADDER: INCONTINENCE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 329, 1993. |
| mouse | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 329, 1993. |
| rat | LD50 | intraperitoneal | 2gm/kg (2000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS KIDNEY, URETER, AND BLADDER: INCONTINENCE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 329, 1993. |
| rat | LD50 | oral | 100mg/kg (100mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 329, 1993. |
| rat | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS KIDNEY, URETER, AND BLADDER: INCONTINENCE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 329, 1993. |
9,10a-Dihydrolisuride Safety Profile
Poison by ingestion and intravenous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes: T.gif){kind=small}
Risk Statements:
23: Toxic by inhalation
24: Toxic in contact with skin
25: Toxic if swallowed
Safety Statements:
36: Wear suitable protective clothing
37: Wear suitable gloves
39: Wear eye/face protection
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
9,10a-Dihydrolisuride Specification
9,10a-Dihydrolisuride (37686-84-3) also can be called Dironyl ; Transdihydrolisuride ; 1,1-Diethyl-3-(6-methylergolin-8alpha-yl)urea ; 6-Methyl-8a-(diethylcarbamoylamino)ergoline ; 6-Methyl-8alpha-(diethylcarbamoylamino)ergoline and 1-((5R,8S,10R)-6-Methyl-8-ergolinyl)-3,3-diethylurea .
What can I do for you?
Get Best Price
